

Fundamental dimension Equity attribute | CBSHPeer $56.07▼-0.78% Cap $8.04BP/E 13.4x QuantScore53/100 | ASBLeader $30.27▲+1.54% Cap $5.02BP/E 10.3x QuantScore59/100 | BANFPeer $111.21▼-1.02% Cap $3.74BP/E 14.6x QuantScore49/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
82/100 |
94/100 |
76/100 |
Valuation Multiples, PEG & DCF upside | 67/100 | 80/100 | 55/100 |
Health Piotroski, Altman Z, leverage & liquidity | 28/100 | 28/100 | 50/100 |
Growth Revenue / earnings growth & margins | 36/100 | 60/100 | 34/100 |
Sentiment Analyst ratings, targets & revisions | 51/100 | 31/100 | 32/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 13.4x | 10.3x | 14.6x |
Forward P/E (next FY) | 13.2x | 10.0x | 14.4x |
EV / EBITDA (TTM) | 10.0x | 8.2x | -1.4x |
Price / Sales | 3.6x | 1.9x | 4.4x |
Price / Free Cash Flow | 6.8x | 7.4x | 20.6x |
PEG ratio | 13.88 | 0.05 | 2.08 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 7 / 9 | 5 / 9 |
Altman Z-Score | -0.32 (Distress) | -0.50 (Distress) | 0.78 (Distress) |
Total debt / equity | 0.65 | 0.88 | 0.00 |
Quick ratio | 0.4x | 0.3x | 373.1x |
Interest coverage | 2.0x | 0.7x | 1.1x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +2.2% | +16.8% | -9.3% |
Net income growth YoY | +7.6% | +285.5% | +11.2% |
Gross margin (TTM) | 81.1% | 61.7% | 84.2% |
Operating margin (FY) | 34.2% | 23.5% | 36.8% |
FCF margin (FY) | 27.7% | 23.6% | 28.7% |
5. Trailing price performancePrice change over period |
1M return | +0.6% | +5.5% | +3.6% |
3M return | -5.1% | +0.0% | -4.6% |
6M return | +10.9% | +8.5% | -2.0% |
Year to date | +7.1% | +17.5% | +4.9% |
1Y return | +10.7% | +19.5% | -1.4% |
3Y return | +46.2% | +94.2% | +37.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $51.61 -7.9% premium | $10.01 -66.9% premium | $46.46 -58.2% premium |
Wall Street consensus target | $65.13 +16.2% · range $60.50–$77.00 | $33.67 +11.2% · range $30.00–$35.00 | $125.00 +12.4% · range $125.00–$125.00 |
Consensus stance | 13% Buy80% Hold7% Sell | 30% Buy60% Hold10% Sell | 0% Buy67% Hold33% Sell |